SciELO - Scientific Electronic Library Online

vol.50 issue2Proteinuria in hypertensive syndrome of pregnancy: maternal and perinatal outcomeEvidence based clinical practice: Part III - Critical appraisal of clinical research author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Revista da Associação Médica Brasileira

Print version ISSN 0104-4230On-line version ISSN 1806-9282


PESARO, Antonio Eduardo Pereira; SERRANO JR., Carlos Vicente  and  NICOLAU, José Carlos. Acute myocardial infarction: acute coronary syndrome with ST-segment elevation. Rev. Assoc. Med. Bras. [online]. 2004, vol.50, n.2, pp.214-220. ISSN 0104-4230.

Cardiovascular diseases continue to be the first cause of death in Brazil - responsible for almost 32% of all deaths. In addition, they are the third major cause of admission in the country. Among them, acute myocardial infarction is still one of the major causes of morbidity and mortality. Despite of the last decade's therapeutic advances, acute myocardial infarction still shows remarkable rates of mortality, and great part of the patients do not receive the adequate treatment. The opening of the Coronary Care Units and the introduction of reperfusion treatment with fibrinolytics or primary angioplasty were fundamental to reduce mortality and complications related to myocardial infarction. Important beneficial effects to the current treatment include less ventricular dysfunction and better control of ventricular arrhythmias. The need of early reperfusion is crucial for the good prognosis after a myocardial infarction. The objective of this review is to emphasize the modern basic concepts of the pathophysiology, diagnosis and treatment of acute myocardial infarction, according to national and international guidelines.

Keywords : Acute myocardial infarction Fibrinolytics; Primary angioplasty.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf epdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License